Do your patients ever wake up with crusty eyelids and clumped up lashes? Do they suffer from irritation, dryness, discomfort, or grittiness in their eyes? Do they experience redness, inflamed eyelids, itchiness, or pain? If the answer is yes, then…
I-MED Pharma Inc., a Canadian company specializing in dry eye diagnosis and management, announced today that the company has launched I-DEFENCE®, a long-lasting, lubricating dry eye ointment that delivers superior moisturizing and protection of the ocular surface. A photo accompanying…
Don’t ignore your eye health. Dry eye disease is a common condition that can affect anyone at any age. It is more important than ever to make sure that you schedule routine eye exams to monitor your eye health and…
Being able to offer patients innovative solutions that have long-lasting effects for their dry eye symptoms can change the scope of an eye care professional’s practice and take it to the next level. With an estimated thirty percent of Canadians…
I-MED Pharma Inc., a Canadian medical device company, announced today that it is collaborating with KMG International Limited to manufacture and supply personal protective equipment (PPE) and COVID-19 diagnostic tests to help respond to the urgent need for these products…
I-MED Pharma Inc., a Canadian company specializing in dry eye diagnosis and management, is proud to announce Health Canada approval for the E>Eye Laser, which is now available to Canadian eye care professionals. With exclusive Canadian distribution rights, I-MED Pharma…
To the essential personnel on the front lines of this global health crisis, we at I-MED Pharma thank you. During this difficult time, a lot of us are self-isolating and working from home. With all the increased exposure to television…
MONTREAL, February 03, 2020 (GLOBE NEWSWIRE) – I-MED Pharma Inc., a Canadian company specializing in dry eye diagnosis and management, announced today that the company has plans to launch its newest, most advanced addition to their I-DROP® artificial tear line,…
Montreal, June 17, 2019 (GLOBE NEWSWIRE) – I-MED Pharma Inc., a Canadian company specializing in dry eye diagnosis and management, announced today that the Canadian Federal Court of Appeal confirmed that TearLab’s efforts to keep the I-PEN® Osmolarity System off…
MONTREAL, May 28, 2019 I-MED Pharma, Inc., a Canadian company specializing in dry eye diagnosis and management is proud to announce the signing of a partnership agreement with prolens AG for exclusive distribution rights of I-LID ’N LASH®, I-LID ’N…
Copyright © 2020 I-MED Pharma inc. All rights reserved.
Privacy | Terms & Conditions
